Within3
Within3 provides an AI-supported SaaS insights management platform that unifies KOL engagement, social listening, advisory boards, and real-world data to help pharmaceutical and biotech companies accelerate product launches and decision-making.
- Company typePrivate
- Founded2007
- HeadquartersLakewood, United States
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What Within3 does
Within3 is a privately held SaaS company founded in 2007 and headquartered in Lakewood/Westlake, Ohio, that provides an AI-supported insights management platform for the life sciences industry. Its flagship product, the Launch Intelligence Platform, unifies field insights, healthcare professional (HCP) and key opinion leader (KOL) engagement, social listening across 800+ digital channels, claims and clinical trial data, scientific publications, and real-world data into a single decision-ready view aimed at pharmaceutical product launches. Platform capabilities include AI-powered Insights Reporting (proprietary NLP trained on medical language, sentiment, and context), KOL Mapping with network analytics that assess influence beyond publication counts, Virtual Advisory Boards with 40+ engagement applications and an AI Moderator Assistant, Social Listening, and the Dataverse ecosystem integrating EHR, claims, and specialty data partners.
The company targets three primary business units within pharmaceutical and biotech organizations: Medical Affairs (KOL engagement, advisory boards, MSL outreach, publication planning), Commercial (market and competitive intelligence, launch readiness), and Clinical/R&D (trial design, site selection, investigator identification). A fourth segment focuses on Emerging Biotechs and first-time launchers with leaner teams and compressed timelines. The business model is annual subscription SaaS with two disclosed tiers (IMP full platform and IMP Basic entry-level), bundled with dedicated client success teams and professional services; pricing is quote-based and not publicly disclosed. Distribution is primarily direct enterprise field sales supplemented by event-driven demand generation at industry conferences (MAPS EMEA, Fierce Pharma Engage) and content marketing.
Within3 is reported as trusted by all top 20 global pharmaceutical companies and 70+ biotechs, with 70,000+ HCPs and patients engaged on the platform. The company completed a $100 million growth funding round in 2020 led by Insight Partners with Silversmith Capital Partners, acquired Voxx Analytics and rMark Bio in 2021, launched the Dataverse ecosystem in February 2026, and appointed Erin Mistry as CEO in June 2026 to lead the next phase of global commercialization. Headcount is reported in the 251-500 range.
Within3 firmographics
Firmographics- Name
- Within3
- Legal name
- Within3, Inc.
- Website
- https://within3.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Within3 provides an AI-supported SaaS insights management platform that unifies KOL engagement, social listening, advisory boards, and real-world data to help pharmaceutical and biotech companies accelerate product launches and decision-making.
- Ownership category
- akta.pro rank
Within3 industry classification
Industry- Product category
- Pharmaceutical Launch Intelligence Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ)
- akta.pro secondary industry
- Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)
Keywords
Where Within3 is headquartered
LocationHeadquarters
- HQ city
- Lakewood
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Within3 business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Revenue model
- SaaS Platform Subscription: Annual or multi-year subscription-based access to the Launch Intelligence platform. The platform offers tiered packages (IMP and IMP Basic) with varying levels of features and data sources included. Dedicated client success team included at no extra cost.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | IMP - Full Insights Management Platform with unlimited group engagement applications, AI-powered Moderator Assistant, comprehensive insights reporting with broad data sources including social listening, congress feeds, KOL mapping, and custom data source support. |
| Subscription | Annual | IMP Basic - Entry-level platform with AI-powered Moderator Assistant and basic insights reporting with limited data sources. |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels8 records
Within3 product offering
Product offeringCore offering
Within3 sells the Launch Intelligence Platform, a subscription-based SaaS system that helps pharmaceutical and biotech companies gather, integrate, and analyze insights from healthcare professionals, key opinion leaders (KOLs), patients, social media, claims data, scientific publications, and clinical trials. The platform enables asynchronous virtual advisory boards, KOL mapping with network analytics, social listening across 800+ sites, AI-supported insights reporting, and a Dataverse ecosystem of real-world data partners to support product launch and stakeholder engagement.
Product overview
Within3 offers the Launch Intelligence Platform—a unified, AI-powered insights management system for life science companies. The core platform unifies field insights, HCP engagement, social sentiment, claims data, and market signals. Key platform features include Insights Reporting (AI-supported analysis and actionable insights), KOL Mapping (network analytics for disease communities), Social Listening (monitoring across 800+ digital channels), Virtual Advisory Boards (40+ engagement applications with AI Moderator Assistant), and Dataverse (ecosystem connecting real-world data from EHR, claims, and specialty data partners). The company also provides specialized services including Clinical Trial Investigators & Site Selection, Publication Planning & Guidelines Review, Patient Journey & Referral Analysis, HCP/Expert Mapping & Segmentation, Institutional Analysis, US Prescription Behavior analysis, and Field Force Research & Optimization. Two pricing tiers are offered: IMP (full-featured) and IMP Basic (entry-level). The platform is trusted by all top 20 pharmaceutical companies and 70+ biotechs.
Differentiator
Problem solved
Functional benefit
Brands
- Launch Intelligence Platform: AI-supported insights management platform for life sciences that unifies field insights, stakeholder engagement, social, claims, and market signals.
- Dataverse
Products and services
- Launch Intelligence Platform Within3's flagship SaaS platform that unifies field insights, stakeholder engagement, social sentiment, claims data, and market signals into a single decision-ready view for pharma and biotech product launches. Trusted by all top 20 pharmaceutical companies and 70+ biotechs.
- Dataverse Ecosystem that connects the Launch Intelligence platform with select data and insight partners to bring EHR, claims, and specialty real-world data into a unified launch decision-making view. Initial partners include Everybody Eats, KAI Conversations, Primum, Thrivable, and Unite Genomics.
- Clinical Trial Investigators & Site Selection Service helping clinical teams identify and connect with influential investigators, map regional expertise and clinical centers, assess investigator performance and patient flow, and gain visibility into KOL research focus and competitor affiliations.
- Publication Planning & Guidelines Review Service helping Medical Affairs teams review and analyze recent publications, conference abstracts, and clinical guidelines to surface emerging themes, evidence gaps, and experts driving the conversation, including KOL identification and network mapping.
- Patient Journey & Referral Analysis Service mapping relationships between primary care providers, specialists, and treatment centers to reveal referral influencers and shape patient access, using claims data to identify HCPs, referral networks, and patient entry points.
- HCP/Expert Mapping & Segmentation Service combining scientific, clinical, and network analytics to map key HCPs and experts by specialty, geography, sponsorship, or scientific expertise, helping identify regional and specialty-specific leaders including emerging influencers post-launch.
- Institutional Analysis Service combining claims and scientific data to identify leading institutions (academic, clinical, practice-based) to align global and regional strategies, strengthen key relationships, and accelerate growth through center of excellence identification.
- US Prescription Behavior Service leveraging real-world prescription data to identify high-value prescribers, optimize targeting strategies, and measure the true impact of commercial activities on prescription growth, with real-time tracking of prescribing trends.
- Field Force Research & Optimization Service delivering data-driven analysis to maximize impact of Medical Affairs and Commercial field forces, building regional call lists, customizing insights for MSLs and field roles, and identifying influential HCPs based on referral networks and patient flow.
Quantifiable outcome
- 90% reduction in analysis and reporting workload
- +6 more outcomes
Companies that use Within3
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Within3 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability9 records
Feature5 records
Within3 partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered flagship, core and strategic.
- ArrayflagshipWithin3 and Array announced a partnership to set new standards in life science stakeholder engagement. The new alliance aims to revolutionize pharma engagement with unprecedented insights.
- Dataverse Ecosystem PartnerscoreWithin3's Dataverse is an invite-only ecosystem of data and insight partners that plug directly into the Launch Intelligence platform. Initial partners include Everybody Eats (commercial analytics), KAI Conversations (conversation intelligence), Primum (cancer point-of-care solutions), Thrivable (patient insights), and Unite Genomics (AI-powered health analytics). The ecosystem brings together partner data, client data, and Within3's own data lake to provide a unified view for launch decision-making.
- Voxx AnalyticsstrategicWithin3 announced acquisition of Voxx Analytics to enhance its offerings for the life science sector. The deal aligns with Within3's product innovation strategy and follows a recent $100 million funding round.
- Lance HillcoreLance Hill serves as CEO of Within3, providing strategic direction and leadership for the company's growth and product development initiatives.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Within3 competitors and assessment
Company assessmentDirect peers
- Veeva Systems: Largest pure-play life-sciences CRM and commercial platform. Directly comparable in serving top-20 pharma KOL, HCP, and stakeholder engagement workflows, with overlapping buyer personas in Medical Affairs and Commercial.
- Medidata Solutions (Dassault Systèmes): Clinical trial technology platform serving pharma and biotech R&D. Comparable in clinical-stakeholder engagement, decentralized trial workflows, and life-sciences buyer base.
- ArisGlobal: Life-sciences R&D and safety software vendor with overlapping buyer personas in Medical Affairs and pharmacovigilance. Comparable in mid-market pharma and biotech deal profiles.
- Science 37: Decentralized clinical trial operator with a virtual engagement model. Comparable in remote stakeholder and patient engagement, particularly in clinical-development workflows.
Broad incumbents
- IQVIA: Global clinical research and commercial intelligence incumbent serving the same top-20 pharma customer base. Comparable in clinical and commercial engagement workflows, but at much larger scale and across a broader services portfolio.
- Oracle Health Sciences: Clinical trial management and pharmacovigilance suite within Oracle's broader health portfolio. Comparable in life-sciences enterprise software, with deeper platform bundling but less specialization in advisory-board engagement.
- Salesforce Health Cloud: Horizontal CRM with a healthcare and life-sciences vertical. Comparable in HCP and stakeholder relationship management, but as a generalist platform rather than a purpose-built life-sciences engagement tool.
Emerging players
- Castor: Clinical trial and real-world data platform for sponsors and CROs. Comparable in decentralized trial workflows and life-sciences buyer base, with a younger, AI-forward product.
- Definitive Healthcare: Healthcare commercial intelligence and analytics platform. Comparable in monetizing proprietary data assets for life-sciences commercial teams, though with a data-licensing rather than workflow model.
- Datavant: Health data connectivity and linking platform serving life sciences and providers. Comparable in building data network effects on top of regulated health data assets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Within3 social profiles
Digital presenceWithin3 compliance and trust
Trust signalCompliance1 record
Within3 financial estimates
Financial estimateRevenue estimate
Valuation estimate
Within3 leadership team
Management profileNumber of profiles
Profiles6 records
Within3 funding detail
Funding detailFunding overview
Funding rounds3 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Within3 M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Within3
What does Within3 do?
Within3 sells the Launch Intelligence Platform, a subscription-based SaaS system that helps pharmaceutical and biotech companies gather, integrate, and analyze insights from healthcare professionals, key opinion leaders (KOLs), patients, social media, claims data, scientific publications, and clinical trials. The platform enables asynchronous virtual advisory boards, KOL mapping with network analytics, social listening across 800+ sites, AI-supported insights reporting, and a Dataverse ecosystem of real-world data partners to support product launch and stakeholder engagement.
Is Within3 a public or private company?
Within3 is a private company. It is classified as venture growth investor backed and is currently operating.
When was Within3 founded?
Within3 was founded in 2007. It employs 251 to 500 people.
Where is Within3 based?
Within3 is headquartered in Lakewood, United States, in the North America region.
How does Within3 make money?
One revenue line is on record: saaS Platform Subscription.
Who are Within3's main competitors?
Direct peers on record are Veeva Systems, Medidata Solutions (Dassault Systèmes), ArisGlobal and Science 37. Broad incumbents are IQVIA, Oracle Health Sciences and Salesforce Health Cloud. Emerging players are Castor, Definitive Healthcare and Datavant.
Does Within3 have an API?
No public API is recorded for Within3.
What industry is Within3 in?
Within3's product category is Pharmaceutical Launch Intelligence Software. Its primary akta.pro industry code is HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up), with a secondary code of HLALABAJ, Patient Engagement, Education & Messaging Platforms (portal/CRM integrated). Its NAICS code is 513210 and its SIC code is 7372.